References
- Alberts MJ. 1991. Circadian variation in stroke. Arch Neurol. 48(8):790. doi:https://doi.org/10.1001/archneur.1991.00530200026011
- Alstadhaug K, Salvesen R, Bekkelund S. 2008. 24-hour distribution of migraine attacks. Headache. 48:95–100. doi:https://doi.org/10.1111/j.1526-4610.2007.00779.x
- AlstadhaugKB,Salvesen R, Bekkelund SI. 2005. Seasonal variation in migraine. Cephalalgia. 25(10):811–816. doi:https://doi.org/10.1111/j.1468-2982.2005.01018.x
- Argentino C, Toni D, Rasura M, Violi F, Sacchetti ML, Allegretta A, Balsano F, Fieschi C. 1990. Circadian variation in the frequency of ischemic stroke. Stroke. 21(3):387–389. doi:https://doi.org/10.1161/01.STR.21.3.387
- AuroraSK, Brin MF. 2017.Chronic Migraine: an Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies. Headache. 57(1):109–125. doi:https://doi.org/10.1111/head.12999
- Aurora SK, Dodick DW, Diener HC, DeGryse RE, Turkel CC, Lipton RB, Silberstein SD. 2014. OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program. Acta Neurol Scand.129(1):61–70. doi:https://doi.org/10.1111/ane.12171
- AuroraSK,Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF, Group PCMS. 2010. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 30(7):793–803. doi:https://doi.org/10.1177/0333102410364676
- Ballesta A, Innominato PF, Dallmann R, Rand DA, Levi FA. 2017. Systems Chronotherapeutics. Pharmacol Rev. 69:161–199. doi:https://doi.org/10.1124/pr.116.013441
- Benedetti F, Barbini B, Colombo C, Smeraldi E. 2007. Chronotherapeutics in a psychiatric ward. Sleep Med Rev. 11(6):509–522. doi:https://doi.org/10.1016/j.smrv.2007.06.004
- Blumenfeld A, Silberstein SD, Dodick DW, Aurora SK, TurkelCC, BinderWJ.2010. Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.Headache.50(9):1406–1418.doi:https://doi.org/10.1111/j.1526-4610.2010.01766.x
- Blumenfeld AM, Silberstein SD, Dodick DW, Aurora SK, Brin MF, Binder WJ. 2017. Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: guidance on Achieving Optimal Outcomes. Headache. 57(5):766–777. doi:https://doi.org/10.1111/head.13074
- Brainard J, Gobel M, Bartels K, Scott B, Koeppen M, Eckle T. 2015. Circadian rhythms in anesthesia and critical care medicine: potential importance of circadian disruptions. Semin Cardiothorac Vasc Anesth. 19(1):49–60. doi:https://doi.org/10.1177/1089253214553066
- Burish MJ, Chen Z, Yoo SH. 2019. Emerging relevance of circadian rhythms in headaches and neuropathic pain. Acta Physiol (Oxf). 225(1):e13161. doi:https://doi.org/10.1111/apha.13161
- Casetta I, Granieri E, Portaluppi F, Manfredini R. 2002. Circadian variability in hemorrhagic stroke. JAMA. 287(10):1266–1267. doi:https://doi.org/10.1001/jama.287.10.1266
- Conway S, Delplanche C, Crowder J, Rothrock J. 2005. Botox therapy for refractory chronic migraine. Headache. 45(4):355–357. doi:https://doi.org/10.1111/j.1526-4610.2005.05073a.x
- Dallaspezia S, Suzuki M, Clara L, Colombo C, Benedetti F. 2018. Chronotype influences response to antidepressant chronotherapeutics in bipolar patients. Chronobiol Int. 35(9):1319–1325. doi:https://doi.org/10.1080/07420528.2018.1469034
- Debon R, Chassard D, Duflo F, Boselli E, Bryssine B, Allaouchiche B. 2002. Chronobiology of epidural ropivacaine: variations in the duration of action related to the hour of administration. Anesthesiology. 96(3):542–545. doi:https://doi.org/10.1097/00000542-200203000-00006
- Dodick DW. 2018. Migraine. Lancet. 391(10127):1315–1330. doi:https://doi.org/10.1016/S0140-6736(18)30478-1
- Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF, Group PCMS, Group PCMS, et al. 2010. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 50(6):921–936. doi:https://doi.org/10.1111/j.1526-4610.2010.01678.x
- Domzal T, Szczudlik A, Kwasucki J, Zaleska B, Lypka A. 1983. Plasma cortisol concentrations in patients with different circadian pain rhythm. Pain. 17(1):67–70. doi:https://doi.org/10.1016/0304-3959(83)90128-8
- Fonken LK, Frank MG, Kitt MM, Barrientos RM, Watkins LR, Maier SF. 2015. Microglia inflammatory responses are controlled by an intrinsic circadian clock. Brain Behav Immun. 45:171–179. doi:https://doi.org/10.1016/j.bbi.2014.11.009
- Frampton JE. 2012. OnabotulinumtoxinA (BOTOX(R)): a review of its use in the prophylaxis of headaches in adults with chronic migraine. Drugs. 72(6):825–845. doi:https://doi.org/10.2165/11208880-000000000-00000
- Gallerani M, Manfredini R, Dal Monte D, Calo G, Brunaldi V, Simonato M. 2001. Circadian differences in the individual sensitivity to opiate overdose. Crit Care Med. 29(1):96–101. doi:https://doi.org/10.1097/00003246-200101000-00021
- Graves DA, Batenhorst RL, Bennett RL, Wettstein JG, Griffen WO, Wright BD, Foster TS. 1983. Morphine requirements using patient-controlled analgesia: influence of diurnal variation and morbid obesity. Clin Pharm. 2:49–53.
- Haus E, Sackett-Lundeen L, Smolensky MH. 2012. Rheumatoid arthritis: circadian rhythms in disease activity, signs and symptoms, and rationale for chronotherapy with corticosteroids and other medications. Bull NYU Hosp Jt Dis. 70(Suppl 1):3–10.
- Headache Classification Committee of the International Headache Society (IHS). 2018. The International Classification of Headache Disorders. 3rd edition. Cephalalgia. 38:1–211. doi:https://doi.org/10.1177/0333102417738202
- Henkel JS, Jacobson M, Tepp W, Pier C, Johnson EA, Barbieri JT. 2009. Catalytic Properties of Botulinum Neurotoxin Subtypes A3 and A4 †. Biochemistry. 48(11):2522–2528. doi:https://doi.org/10.1021/bi801686b
- Hermida RC, Hermida-Ayala RG, Smolensky MH, Mojon A, Fernandez JR. 2020a. Ingestion-time - relative to circadian rhythms - differences in the pharmacokinetics and pharmacodynamics of hypertension medications. Expert Opin Drug Metab Toxicol. 1–15. doi:https://doi.org/10.1080/17425255.2020.1825681
- Hermida RC, Mojon A, Fernandez JR. 2020b. Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as documented by MAPEC and Hygia Chronotherapy outcomes trials. Chronobiol Int. 37(5):731–738. doi:https://doi.org/10.1080/07420528.2020.1771354
- Junker U, Wirz S. 2010. Review article: chronobiology: influence of circadian rhythms on the therapy of severe pain. J Oncol Pharm Pract. 16(2):81–87. doi:https://doi.org/10.1177/1078155209337665
- Kiem DT, Fekete MI, Makara GB. 1995. Diurnal alteration in opiate effects on the hypothalamo-pituitary-adrenal axis: changes in the mechanism of action. Eur J Pharmacol. 272(2–3):145–150. doi:https://doi.org/10.1016/0014-2999(94)00639-O
- Komiyama O, Wang K, Svensson P, Arendt-Nielsen L, De Laat A. 2005. Gender difference in masseteric exteroceptive suppression period and pain perception. Clin Neurophysiol. 116(11):2599–2605. doi:https://doi.org/10.1016/j.clinph.2005.07.017
- Lemmer B, Labrecque G. 1987. Chronopharmacology and chronotherapeutics: definitions and concepts. Chronobiol Int. 4(3):319–329. doi:https://doi.org/10.3109/07420528709083522
- Levi F. 2006. Chronotherapeutics: the relevance of timing in cancer therapy. Cancer Causes Control. 17(4):611–621. doi:https://doi.org/10.1007/s10552-005-9004-7
- Montal M. 2010. Botulinum neurotoxin: a marvel of protein design. Annu Rev Biochem. 79(1):591–617. doi:https://doi.org/10.1146/annurev.biochem.051908.125345
- Packard A, Bautista R, Smotherman C, Gautham S. 2020. Gender differences in Epworth Sleepiness Scale revealed by paired patient-spouse scoring. Epilepsy Behav. 107272. doi:https://doi.org/10.1016/j.yebeh.2020.107272
- Packard A, Smotherman C, Jovanovic N. 2020. Effect of circadian rhythm on the pain associated with preventive onabotulinumtoxinA injections for migraines. Chronobiol Int. 1–6. doi:https://doi.org/10.1080/07420528.2020.1802290.
- Pellett S, Bradshaw M, Tepp WH, Pier CL, Whitemarsh RCM, Chen C, Barbieri JT, Johnson EA. 2018. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes. mBio. 9(2):e00089-18. doi:https://doi.org/10.1128/mBio.00089-18
- Pellett S, Tepp WH, Whitemarsh RC, Bradshaw M, Johnson EA. 2015. In vivo onset and duration of action varies for botulinum neurotoxin A subtypes 1-5. Toxicon. 107:37–42. doi:https://doi.org/10.1016/j.toxicon.2015.06.021
- Peres MFP, Oliveira AB, Mercante JP, Kamei HH, Tobo PR, Rozen TD, Levin M, Buse DC, Lucchetti G. 2019. Optimism, Pessimism, and Migraine: A Cross-Sectional, Population-BasedStudy.Headache.59(2):205–214. doi:https://doi.org/10.1111/head.13471
- Pier CL, Chen C, Tepp WH, Lin G, Janda KD, Barbieri JT, Pellett S, Johnson EA. 2011. Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1. FEBS Lett. 585(1):199–206. doi:https://doi.org/10.1016/j.febslet.2010.11.045
- Portaluppi F, Touitou Y, Smolensky MH. 2008. Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol Int. 25(6):999–1016. doi:https://doi.org/10.1080/07420520802544530
- Rasmussen HN, Scheier MF, Greenhouse JB. 2009. Optimism and physical health: a meta-analytic review. Ann Behav Med. 37(3):239–256. doi:https://doi.org/10.1007/s12160-009-9111-x
- Ruben MD, Hogenesch JB, Smith DF. 2019. Sleep and Circadian Medicine: time of Day in the Neurologic Clinic. Neurol Clin. 37(3):615–629. doi:https://doi.org/10.1016/j.ncl.2019.03.004
- Rummel A. 2013. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Curr Top Microbiol Immunol. 364:61–90. doi:https://doi.org/10.1007/978-3-642-33570-9_4
- Savarino V, Mela GS, Zentilin P, Malesci A, Vigneri S, Sossai P, Di Mario F, Cutela P, Mele MR, Celle G. 1993. Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. Scand J Gastroenterol. 28(9):772–776. doi:https://doi.org/10.3109/00365529309104007
- Scheier MF, Carver CS. 2018. Dispositional optimism and physical health: A long look back, a quick look forward. Am Psychol. 73(9):1082–1094. doi:https://doi.org/10.1037/amp0000384
- Segal JP, Tresidder KA, Bhatt C, Gilron I, Ghasemlou N. 2018. Circadian control of pain and neuroinflammation. J Neurosci Res. 96:1002–1020.
- Silberstein SD, Dodick DW, Aurora SK, Diener HC, DeGryse RE, Lipton RB, Turkel CC. 2015. Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT. J Neurol Neurosurg Psychiatry. 86(9):996–1001. doi:https://doi.org/10.1136/jnnp-2013-307149
- Smolensky MH. 1996. Chronobiology and chronotherapeutics. Applications to cardiovascular medicine. Am J Hypertens. 9(4):11S–21S. doi:https://doi.org/10.1016/0895-7061(95)00405-X
- Smolensky MH, Lemmer B, Reinberg AE. 2007. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev. 59(9–10):852–882. doi:https://doi.org/10.1016/j.addr.2007.08.016
- Smolensky MH, Martin RJ. 1999. Nocturnal asthma: role of circadian rhythms in its mechanisms and therapy. Chronobiol Int. 16(5):vii–ix. doi:https://doi.org/10.3109/07420529908998727
- Torii Y, Goto Y, Nakahira S, Kozaki S, Ginnaga A. 2014. Comparison of the immunogenicity of botulinum toxin type A and the efficacy of A1 and A2 neurotoxins in animals with A1 toxin antibodies. Toxicon. 77:114–120. doi:https://doi.org/10.1016/j.toxicon.2013.11.006
- Torii Y, Kiyota N, Sugimoto N, Mori Y, Goto Y, Harakawa T, Nakahira S, Kaji R, Kozaki S, Ginnaga A. 2011. Comparison of effects of botulinum toxin subtype A1 and A2 using twitch tension assay and rat grip strength test. Toxicon. 57(1):93–99. doi:https://doi.org/10.1016/j.toxicon.2010.10.009
- Vieira WS, Hidalgo MP, Torres Ida S, Caumo W. 2010. Biological rhythms of spinal-epidural labor analgesia. Chronobiol Int. 27(4):865–878. doi:https://doi.org/10.3109/07420521003721914